Stay updated on Pembrolizumab and Lenvatinib in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Lenvatinib in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Lenvatinib in Melanoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Added a Publications entry with a 2025 LEAP-003 study article citation and a Study Results section, and removed two older update dates (2025-10-17 and 2025-10-01).
    Difference
    0.4%
    Check dated 2025-11-03T20:36:50.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Added a government operating status notice and updated version to v3.2.0; removed the previous v3.1.0 tag.
    Difference
    2%
    Check dated 2025-10-06T04:30:54.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Appended version label (v3.1.0) and removal of multiple drug-safety related sections, indicating content consolidation and reorganization rather than new substantive content.
    Difference
    0.2%
    Check dated 2025-09-29T01:14:23.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The revision label updated from v3.0.1 to v3.0.2, indicating a minor release. The Back to Top element was removed, with no other substantive content changes evident.
    Difference
    0.1%
    Check dated 2025-09-14T18:49:02.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.1%
    Check dated 2025-09-07T13:13:48.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of numerous location entries across various countries and the removal of several previous location listings. Additionally, there are updates to MedlinePlus related topics, specifically the inclusion of 'Drug Safety' and 'Substandard Drugs'.
    Difference
    13%
    Check dated 2025-08-31T11:10:53.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Lenvatinib in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Lenvatinib in Melanoma Clinical Trial page.